BEGIN:VCALENDAR
PRODID:-//AT Content Types//AT Event//EN
VERSION:2.0
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20120525T145525Z
CREATED:20080213T212050Z
UID:ATEvent-344d23e00940d54f8979b22f9b2b8c9b
LAST-MODIFIED:20080213T212404Z
SUMMARY:Topics and Tactics in Current Drug Design
DTSTART:20081020T042000Z
DTEND:20081022T042000Z
DESCRIPTION:The “Topics and Tactics in Current Drug Design” confer
 ence will be chaired by Dr. Nicholas A. Meanwell\, Executive Director 
 of Discovery Chemistry at Bristol-Myers Squibb Research and Developmen
 t\, and Dr. Milind S. Deshpande\, Executive Vice President of Research
  & Chief Scientific Officer of Achillion Pharmaceuticals\, Inc.\n\nThe
  expeditious and successful development of drug candidates requires a 
 detailed understanding of drug-target interactions and an appreciation
  for the many off-target sources of drug failure.  This ACS Prospectiv
 es conference will look broadly at contemporary topics in drug design 
 and discovery by exploring many of the problems commonly faced by medi
 cinal chemists.  Each session will emphasize fundamental aspects of dr
 ug design\, providing comprehensive synopses of the kinds of tactics a
 nd strategies that have led to the optimization of drug-target interac
 tions against the backdrop of enhancing drug safety and compound deliv
 ery in vivo.
CATEGORIES:Conference
CONTACT:\, 1- (800) 227-5558\, acsprospectives@acs.org
URL:http://portal.acs.org/portal/acs/corg/content?_nfpb=true&_pageLabel=PP_ARTICLEMAIN&node_id=147&content_id=WPCP_008127&use_sec=true&sec_url_var=region1
CLASS:PUBLIC
END:VEVENT
END:VCALENDAR